Clinical Trial Update: MSA-01 in Multiple System Atrophy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of MSA-01 for Multiple System Atrophy is currently recruiting, sponsored by The University of Tokyo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• MSA-01

Snippet

Sponsor: Tokyo University | Conditions: Multiple System Atrophy (MSA) | Phase 3 | Status: RECRUITING